These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 30487265

  • 1. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H, Yang W, Zhou F, Li X, Pan Q, Shen Z, Han G, Newell-Fugate A, Tian Y, Majeti R, Liu W, Xu Y, Wu C, Allred K, Allred C, Sun Y, Guo S.
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [Abstract] [Full Text] [Related]

  • 2. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W, Liao W, Li X, Ai W, Pan Q, Shen Z, Jiang W, Guo S.
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [Abstract] [Full Text] [Related]

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ.
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [Abstract] [Full Text] [Related]

  • 4. Metformin Targets Foxo1 to Control Glucose Homeostasis.
    Guo X, Li X, Yang W, Liao W, Shen JZ, Ai W, Pan Q, Sun Y, Zhang K, Zhang R, Qiu Y, Dai Q, Zheng H, Guo S.
    Biomolecules; 2021 Jun 11; 11(6):. PubMed ID: 34208360
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A, Yan H, Liang J, Du C, Zhao X, Sun L, Chen Y.
    Gene; 2017 Sep 05; 627():194-201. PubMed ID: 28627440
    [Abstract] [Full Text] [Related]

  • 6. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C, Zheng Y, Hu S, Liang X, Li Y, Yu Z, Liu Y, Bian Y, Man Y, Zhao S, Liu X, Liu H, Huang T, Ma J, Chen ZJ, Zhao H, Zhang Y.
    Metabolism; 2024 Mar 05; 152():155766. PubMed ID: 38145825
    [Abstract] [Full Text] [Related]

  • 7. Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis.
    Liao W, Yang W, Shen Z, Ai W, Pan Q, Sun Y, Guo S.
    Diabetes; 2021 Mar 05; 70(3):696-709. PubMed ID: 33408127
    [Abstract] [Full Text] [Related]

  • 8. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q, Ai W, Chen Y, Kim DM, Shen Z, Yang W, Jiang W, Sun Y, Safe S, Guo S.
    Diabetes; 2023 Sep 01; 72(9):1193-1206. PubMed ID: 37343276
    [Abstract] [Full Text] [Related]

  • 9. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
    Li X, Chen Y, Shen JZ, Pan Q, Yang W, Yan H, Liu H, Ai W, Liao W, Guo S.
    J Agric Food Chem; 2019 Apr 03; 67(13):3651-3661. PubMed ID: 30875211
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin F Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity.
    Wang Y, Yan S, Xiao B, Zuo S, Zhang Q, Chen G, Yu Y, Chen D, Liu Q, Liu Y, Shen Y, Yu Y.
    Diabetes; 2018 Sep 03; 67(9):1748-1760. PubMed ID: 29773555
    [Abstract] [Full Text] [Related]

  • 11. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F, Shao Q, Xia Q, Hu M, Zhao Y, Wang D, Fang K, Xu L, Zou X, Chen Z, Chen G, Lu F.
    Phytomedicine; 2021 Mar 03; 83():153487. PubMed ID: 33636476
    [Abstract] [Full Text] [Related]

  • 12. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
    Besse-Patin A, Jeromson S, Levesque-Damphousse P, Secco B, Laplante M, Estall JL.
    Proc Natl Acad Sci U S A; 2019 Mar 05; 116(10):4285-4290. PubMed ID: 30770439
    [Abstract] [Full Text] [Related]

  • 13. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W, Zhao Y, Yang Y, Ding Z, Xu X, Weng D, Wang S, Cheng R, Zhang J.
    J Biol Chem; 2021 Jul 05; 297(1):100846. PubMed ID: 34058194
    [Abstract] [Full Text] [Related]

  • 14. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP, Lee MC, Foufelle F, Sajan J, Cleland C, Farese RV.
    Cell Signal; 2018 Mar 05; 43():62-70. PubMed ID: 29269047
    [Abstract] [Full Text] [Related]

  • 15. Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis.
    Wu Y, Pan Q, Yan H, Zhang K, Guo X, Xu Z, Yang W, Qi Y, Guo CA, Hornsby C, Zhang L, Zhou A, Li L, Chen Y, Zhang W, Sun Y, Zheng H, Wondisford F, He L, Guo S.
    Diabetes; 2018 Nov 05; 67(11):2167-2182. PubMed ID: 30201683
    [Abstract] [Full Text] [Related]

  • 16. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z, Ding L, Yang W, Wang J, Chen L, Chang Y, Geng B, Cui Q, Guan Y, Yang J.
    Diabetes; 2017 May 05; 66(5):1185-1197. PubMed ID: 28246289
    [Abstract] [Full Text] [Related]

  • 17. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
    Yan C, Chen J, Li M, Xuan W, Su D, You H, Huang Y, Chen N, Liang X.
    Diabetologia; 2016 Jul 05; 59(7):1524-1532. PubMed ID: 27003684
    [Abstract] [Full Text] [Related]

  • 18. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L, Ding X, Wang Y, Gu M, Zhang J, Yan S, Li N, Song Z, Yin J, Lu L, Peng Y.
    Int J Biol Sci; 2019 Jul 05; 15(13):2815-2829. PubMed ID: 31853220
    [Abstract] [Full Text] [Related]

  • 19. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
    Aljaylani A, Fluitt M, Piselli A, Shepard BD, Tiwari S, Ecelbarger CM.
    Cell Physiol Biochem; 2020 Jul 18; 54(4):682-695. PubMed ID: 32678535
    [Abstract] [Full Text] [Related]

  • 20. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F, Ying HM, Wang YY, Cheng BN, Chen J.
    Yonsei Med J; 2020 Sep 18; 61(9):780-788. PubMed ID: 32882762
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.